Paper · 40926657

Smaller hippocampal tail volume is associated with plasma CCL11 levels in patients with major depressive disorder.

Wu L and 8 others. Psychol Med, 2025. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Smaller hippocampal tail volume is associated with plasma CCL11 levels in patients with major depressive disorder. Papers, record 40926657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40926657

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Smaller hippocampal tail volume is associated with plasma CCL11 levels in patients with major depressive disorder.; PubMed
Journal: Psychol Med; PubMed
Year: 2025; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/40926657/; PubMed
DOI: https://doi.org/10.1017/s0033291725101402; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13040599/; PubMed
The journal: https://conductscience.org/library/journal-index/1254142; PubMed
Citations, by iCite: 0; iCite
Revised in PubMed: 2026-08-13; PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Wu L	Longhai
2	Liu Y	Yilin
3	Kong L	Lingtao
4	Yan X	Xintong
5	Lu Y	Yihui
6	Jiang X	Xiaowei
7	Zhou Y	Yifang
8	Sun Q	Qikun
9	Wu F	Feng	https://orcid.org/0000-0003-4322-1447

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Major Depressive Disorder	Major topic
Hippocampus	Major topic
Chemokine CCL11	Major topic
Humans
Female
Male
Adult
Magnetic Resonance Imaging
Middle Aged
Case-Control Studies
Young Adult

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
2022-YGJC-40 and 2024-84	Natural Science Foundation of Liaoning Province			PubMed
82201689	National Natural Science Foundation of China			PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	37,263,267	Orbitofrontal cortex-hippocampus potentiation mediates relief for depression: A randomized double-blind trial and TMS-EEG study.	Cell Rep Med	2023	https://conductscience.org/library/papers/37263267	PubMed
2	34,086,364	Eotaxin (CCL11) enhances mediator release from human basophils.	Allergy	2021	https://conductscience.org/library/papers/34086364	PubMed
3	26,657,967	Influence of reward motivation on human declarative memory.	Neurosci Biobehav Rev	2016	https://conductscience.org/library/papers/26657967	PubMed
4	19,778,943	Eotaxin increases monolayer permeability of human coronary artery endothelial cells.	Arterioscler Thromb Vasc Biol	2009	https://conductscience.org/library/papers/19778943	PubMed
5	17,647,290	Spatial arrangement of microglia in the mouse hippocampus: a stereological study in comparison with astrocytes.	Glia	2007	https://conductscience.org/library/papers/17647290	PubMed
6	25,983,019	Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder.	Eur Neuropsychopharmacol	2015	https://conductscience.org/library/papers/25983019	PubMed
7	37,931,808	Chronic pain accelerates cognitive impairment by reducing hippocampal neurogenesis may via CCL2/CCR2 signaling in APP/PS1 mice.	Brain Res Bull	2023	https://conductscience.org/library/papers/37931808	PubMed
8	31,610,545	Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report.	Neuropsychopharmacology	2020	https://conductscience.org/library/papers/31610545	PubMed
9	26,184,677	CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia.	Glia	2015	https://conductscience.org/library/papers/26184677	PubMed
10	34,051,145	Resolving cellular and molecular diversity along the hippocampal anterior-to-posterior axis in humans.	Neuron	2021	https://conductscience.org/library/papers/34051145	PubMed

1 to 10 of 70

See all 70 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
CCL11	6,356	PubTator's text mining	https://conductscience.org/library/genes/6356	NCBI Gene
CCL2	6,347	PubTator's text mining	https://conductscience.org/library/genes/6347	NCBI Gene
CCL7	6,354	PubTator's text mining	https://conductscience.org/library/genes/6354	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40926657

GET https://conductscience.org/api/papers/v1/40926657/references?page=2

API reference For AI assistants